Stockreport

How The FDA's Decision On Aducanumab May Affect The Value Of Biogen's Stock [Seeking Alpha]

EISAI CO S/ADR  (ESALY) 
NASDAQ:AMEX Investor Relations: eisai.com/ir/index.html
PDF In November 2019, Biogen’s (BIIBI don’t think the field has ever seen data like this,' said Sandrock … Sandrock didn’t offer a prediction, but if the FDA rejects the dru [Read more]